International AIDS Vaccine Initiative And Theraclone Sciences, Inc. Expand HIV Antibody Discovery Collaboration

SEATTLE & NEW YORK--(BUSINESS WIRE)--Theraclone Sciences, Inc. and the International AIDS Vaccine Initiative (IAVI) have announced an expansion of their HIV antibody discovery program.